cardiology anaesthesia-icu
SAVE Score for Survival After Veno-Arterial ECMO (VA-ECMO)
Validated pre-ECMO score predicting in-hospital survival for patients requiring veno-arterial ECMO for refractory cardiogenic shock. Helps guide patient selection and family counselling.
References
- Schmidt M et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246-2256.
- Combes A et al. Extracorporeal membrane oxygenation for severe acute respiratory failure in adults. JAMA. 2018;319(8):777-791.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Noradrenaline (Cardiogenic Shock / Vasopressor) · Vasopressor / Cardiogenic Shock
- Hydrocortisone (ICU — Stress Dosing) · Corticosteroid (ICU/Septic Shock)
- Ranolazine · Refractory Stable Angina
- Selexipag · Pulmonary Arterial Hypertension
- Macitentan · Pulmonary Arterial Hypertension
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.